<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our objective was to determine the HLA-DPB1 allele associations of anticardiolipin (aCL) and anti-beta2GPI (a(beta)2GPI) antibodies, and of clinical manifestations of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS), in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 577 European patients with SLE </plain></SENT>
<SENT sid="2" pm="."><plain>aCL and a(beta)2GPI antibodies were measured by ELISA </plain></SENT>
<SENT sid="3" pm="."><plain>Molecular typing of HLA-DPB1 locus was performed by polymerase chain reaction-sequence specific oligonucleotide probe (PCR-SSOP) method </plain></SENT>
<SENT sid="4" pm="."><plain>aCL showed positive association with -DPB1*1501 (P = 0.005, OR = 7.4), and -DPB1*2301 (P = 0.009, OR = 3.3) </plain></SENT>
<SENT sid="5" pm="."><plain>a(beta)2GPI showed positive association with -DPB1*0301 (P = 0.01, OR = 1.9), and -DPB1*1901 (P = 0.004, OR = 8.1) </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> was associated with -DPB1*1401, and <z:e sem="disease" ids="C0034735" disease_type="Disease or Syndrome" abbrv="">Raynaud's phenomenon</z:e> with -DPB1*2001 </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, HLA-DPB1 locus may contribute to the genetic predisposition to develop <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and clinical manifestations of the APS in patients with SLE </plain></SENT>
</text></document>